NPPA fixes ceiling prices for 84 drug formulations; focus on Empagliflozin-based Diabetes therapies Ruchika Sharma8 May 2025 2:14 PM ISTNew Delhi: In a fresh directive aimed at curbing treatment costs and improving access to essential medicines, the National Pharmaceutical Pricing...
4 Diabetes Medication FDCs including Glimipride Metformin Strength banned by Health Ministry Farhat Nasim18 April 2025 6:13 PM ISTDelhi: The Central Drugs Standard Control Organization (CDSCO) has banned the manufacture, sale, and distribution of certain widely used strengths of...
Govt Bans 35 Combination Drugs, See Full List Farhat Nasim16 April 2025 8:36 PM ISTNew Delhi: The Central Drugs Standard Control Organisation (CDSCO) has issued a stern directive to all State and Union Territory Drug...
Right Turn Show- Exploring Dapagliflozin Beyond Glycemic Benefits Deeksha Bhandari8 April 2025 12:34 PM ISTIn the last episode, we explored the role of Dapagliflozin in specialty care settings. Moving forward, this episode delves into Dapagliflozin Beyond...
NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings MD Brand Connect18 Dec 2024 12:00 PM ISTPresenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin...
Indian Pharma Market grows at 6.8 percent in October, Chronic Therapies Dominate: IQVIA Farhat Nasim19 Nov 2024 6:19 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) experienced a significant 6.8% increase in Total Sales Audit (TSA) over the 12-month period ending...
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Dapagliflozin Glimepiride Metformin FDC in Uncontrolled T2DM with HbA1c >9 % Dr Rajeev Chawla8 Oct 2024 12:24 PM ISTIntroductionIndia has the second highest rate of diabetes in the world. (1) According to the ICMR-INDIAB-17 study, the prevalence of diabetes in India...
Sun Pharma Laboratories Gets CDSCO Panel Nod To study Antidiabetic FDC Drug Dr. Divya Colin28 Jun 2024 6:00 PM ISTNew Delhi: The drug major Sun Pharma Laboratories has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
Glipizide-Metformin, Glimepiride-Metformin-Pioglitazone FDCs Reduce Medication Costs in Indian T2DM: Study Dr. Kamal Kant Kohli27 May 2024 11:30 AM ISTAffordable combination medicines, such as glipizide + metformin and glimepiride + metformin + pioglitazone offer considerable advantages and can...
Affordable Combinations in T2DM care: Scope of Glipizide, Metformin and Glimepiride, Metformin, Pioglitazone MDTV Bureau20 May 2024 11:31 AM ISTDual therapy of Glipizide + Metformin and the triple drug combination of Glimepiride + Metformin + Pioglitazone emerges as effective, safe, and...
